Action Changement Date
argenx SE USD 371M 102.53M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
Biogen USD 2.22B 159.9M 2026-09
Genmab DKK 21M 8M 2026-03
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
GRIFOLS EUR 3.47B 23M 2026-09
Hikma Pharmaceutical USD 1.11B 24M 2025-12
Incyte USD 134.25M 21.71M 2026-09
Merck EUR 4.89B 104M 2026-06
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Novartis USD 6.1B 116M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
UCB EUR 1.31B 173M 2024-12
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09